Researchers at UCLA and Cedars-Sinai Medical Center were awarded about $5.6 million in grants Thursday aimed at funding efforts to remove technological barriers to moving stem-cell research projects into clinical trials.
The California Institute for Regenerative Medicine (CIRM) awarded nearly $33 million in grants to 19 researchers across the state.
“These awards are a crucial component of CIRM’s commitment to accelerate the development of stem cell-based therapies for people of the world,” CIRM President Alan Trounson said. “CIRM funds all stages of therapy development, from basic research to translational awards, but any of these could be stalled by technological bottlenecks. In funding these innovative tools and technologies, CIRM is removing those barriers before they can delay cures.”
In further news CIRM released an independent economic impact study that shows CIRM has already delivered significant financial benefit for the state with its first $1.1 billion in grants creating 25,000 job years and $200 million in new tax revenue through 2014